Seqanswers Leaderboard Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ThePresident
    Member
    • Jun 2012
    • 72

    Understanding VCF output from mpileup

    Hello,

    As a start, I would like to mention that I just passed 2 hours reading older threads here and on biostar as well as the VCF specification sheet.

    That been said, I have a question upon calling a SNPs from RNA-seq data (Illumina signle-read, bacterial) with mpileup. I got my VCF file and I'm struggling a little bit to understand the output. If I have:

    Code:
    gi|xxx|emb|xxx|	143630	.	C	T	999	.	DP=490	VDB=0.0004	AF1=1	AC1=4	DP4=1,0,211,276	MQ=20	FQ=-286	PV4=0.43,1.5e-11,1,0.048		GT:PL:GQ	1/1:255,255,0:99	1/1:255,255,0:99
    I'm pretty sure of the following:
    1. 143630 is the position of my SNPs
    2. C is the base in the reference genome and T the alternate variant (actual SNPs)
    3. 999 is the score. The higher it is, better the chances that the call is genuine
    4. DP is the actual coverage on that specific position
    5. DP4 are reads fwd and rev for reference and fwd and rev for alternate call
    6. MQ is the quality


    Now, here are my questions:
    1. VDB is supposed to be Variant Distance Bias. What exaclt does it means and how I interpret it?
    2. AF1 is Allele Frequency. By 1 it means that all the reads are calling the SNPs? If I have AF1=0.5, it means that half of the reads are calling ref nucleotide while the other half is calling SNP?
    3. What the heck is AC1? Max likelihood okay, but how you interpret it?
    4. How do you interpret FQ (Phred probability), i.e. lower vs higher?
    5. PV4 is a total mess... Any insight would be greatly appreciated.
    6. GT:PL:GQ: same as above.


    I know that this is probably very basic for most of you, but I'm just trying to make some sense out of it...

    Thank you all in advance,

    TP

Latest Articles

Collapse

  • seqadmin
    Pathogen Surveillance with Advanced Genomic Tools
    by seqadmin




    The COVID-19 pandemic highlighted the need for proactive pathogen surveillance systems. As ongoing threats like avian influenza and newly emerging infections continue to pose risks, researchers are working to improve how quickly and accurately pathogens can be identified and tracked. In a recent SEQanswers webinar, two experts discussed how next-generation sequencing (NGS) and machine learning are shaping efforts to monitor viral variation and trace the origins of infectious...
    03-24-2025, 11:48 AM
  • seqadmin
    New Genomics Tools and Methods Shared at AGBT 2025
    by seqadmin


    This year’s Advances in Genome Biology and Technology (AGBT) General Meeting commemorated the 25th anniversary of the event at its original venue on Marco Island, Florida. While this year’s event didn’t include high-profile musical performances, the industry announcements and cutting-edge research still drew the attention of leading scientists.

    The Headliner
    The biggest announcement was Roche stepping back into the sequencing platform market. In the years since...
    03-03-2025, 01:39 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 03-20-2025, 05:03 AM
0 responses
41 views
0 reactions
Last Post seqadmin  
Started by seqadmin, 03-19-2025, 07:27 AM
0 responses
49 views
0 reactions
Last Post seqadmin  
Started by seqadmin, 03-18-2025, 12:50 PM
0 responses
36 views
0 reactions
Last Post seqadmin  
Started by seqadmin, 03-03-2025, 01:15 PM
0 responses
192 views
0 reactions
Last Post seqadmin  
Working...